RK
Insider
Randal J Kirk
DirectorRandal J Kirk (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Precigen, Inc. (PGEN). The largest single filing was $15.7M of PGEN (4,748,992 sh across 10 lots, as filed), executed Mar 30.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$35.7M
shares × price, as filed
Last traded
Mar 30
Filed Mar 31
Median ADV $37.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $60.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
PGENRecent filings
PGENSALE
Precigen, Inc.
View filing →
$15.7M4,748,992 sh across 10 lots
Exec Mar 30
Filed Mar 31 · 5:30 PM ET PGENSALE Precigen, Inc. View filing → $7.7M
1,846,412 sh across 6 lots
Exec Dec 22 2025
Filed Dec 22 2025 · 5:30 PM ET PGENSALE Precigen, Inc. View filing → $12.3M
2,966,293 sh across 3 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET PGENSALE Precigen, Inc. View filing → $6.2M
1,809,667 sh × $3.41
Exec Sep 30 2025
Filed Sep 30 2025 · 5:30 PM ET PGENSALE Precigen, Inc. View filing → $18.7M
5,000,252 sh across 2 lots
Exec Sep 18 2025
Filed Sep 19 2025 · 5:30 PM ET